Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Ralston

Showing results (81-90 of 275) with videos related to

Pageof 28
Sort By:
BMJ Case Reports|April 22, 2026
Large vessel vasculitis post granulocyte-colony stimulating factor (G-CSF) use in a patient undergoing neoadjuvant chemotherapy for pancreatic adenocarcinomaFlora Mr Hay, Tze-En Ding, Stuart H Ralston, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2010
Discovery of biphenylketones as dual modulators of inflammation and bone lossIain R Greig, Emmanuel Coste, Stuart H Ralston, et al.
Archives of Biochemistry and Biophysics|December 9, 2008
Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanismsSarah J Aitken, Euphemie Landao-Bassonga, Stuart H Ralston, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 23, 2019
Liver-derived IGF-I is not required for protection against osteoarthritis in male miceAnna E Törnqvist, Antonia Sophocleous, Stuart H Ralston, et al.
Calcified Tissue International|July 2, 2021
Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In VitroKatherine A Staines, Katherine Myers, Kirsty Little, et al.
Aging Cell|July 29, 2017
Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibitionAntonia Sophocleous, Silvia Marino, Dilruba Kabir, et al.
Annals of the Rheumatic Diseases|February 23, 2025
Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fracturesBarbara Hauser, Andrew Merriman, Jonathan Foley, et al.
The Journal of Biological Chemistry|December 21, 2002
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant proteinKatrien Janssens, Peter ten Dijke, Stuart H Ralston, et al.
Human Molecular Genetics|May 12, 2009
Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosisHuilin Jin, Rob J van't Hof, Omar M E Albagha, et al.
BMJ Case Reports|November 29, 2012
Polyarteritis nodosa presenting as haematuria following strenuous exerciseAlison Bing, Charles Rich, Julian Y Keanie, et al.
Pageof 28

Showing results (81-90 of 275) with videos related to

Sort By:
Pageof 28
BMJ Case Reports|April 22, 2026
Large vessel vasculitis post granulocyte-colony stimulating factor (G-CSF) use in a patient undergoing neoadjuvant chemotherapy for pancreatic adenocarcinomaFlora Mr Hay, Tze-En Ding, Stuart H Ralston, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2010
Discovery of biphenylketones as dual modulators of inflammation and bone lossIain R Greig, Emmanuel Coste, Stuart H Ralston, et al.
Archives of Biochemistry and Biophysics|December 9, 2008
Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanismsSarah J Aitken, Euphemie Landao-Bassonga, Stuart H Ralston, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 23, 2019
Liver-derived IGF-I is not required for protection against osteoarthritis in male miceAnna E Törnqvist, Antonia Sophocleous, Stuart H Ralston, et al.
Calcified Tissue International|July 2, 2021
Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In VitroKatherine A Staines, Katherine Myers, Kirsty Little, et al.
Aging Cell|July 29, 2017
Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibitionAntonia Sophocleous, Silvia Marino, Dilruba Kabir, et al.
Annals of the Rheumatic Diseases|February 23, 2025
Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fracturesBarbara Hauser, Andrew Merriman, Jonathan Foley, et al.
The Journal of Biological Chemistry|December 21, 2002
Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant proteinKatrien Janssens, Peter ten Dijke, Stuart H Ralston, et al.
Human Molecular Genetics|May 12, 2009
Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosisHuilin Jin, Rob J van't Hof, Omar M E Albagha, et al.
BMJ Case Reports|November 29, 2012
Polyarteritis nodosa presenting as haematuria following strenuous exerciseAlison Bing, Charles Rich, Julian Y Keanie, et al.
Pageof 28